TRDA Entrada Therapeutics Inc

P/E --

Forward P/E 3333.33

Price/Sales 36.64

Beta -0.238

Div Yield --

Market Cap --

Company Analysis

Latest News

November 04, 2026

Entrada Therapeutics Inc Q3 2026 Earnings Preview: What Analysts Expect on November 05, 2026

Entrada Therapeutics is expected to report Q3 2026 results on November 5, with analysts forecasting a consensus revenue of $2.13 million and an EPS loss of...